293 filings
6-K
CMMB
Chemomab Therapeutics Ltd
12 Jun 24
Current report (foreign)
4:02pm
6-K
CMMB
Chemomab Therapeutics Ltd
9 May 24
Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides
7:00am
6-K
CMMB
Chemomab Therapeutics Ltd
8 May 24
Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance
7:05am
6-K
CMMB
Chemomab Therapeutics Ltd
3 May 24
Current report (foreign)
4:03pm
20-F
2023 FY
CMMB
Chemomab Therapeutics Ltd
Annual report (foreign)
28 Mar 24
6:03am
SC 13D/A
CMMB
Chemomab Therapeutics Ltd
11 Mar 24
Chemomab Therapeutics / OrbiMed Israel BioFund GP Limited Partnership ownership change
7:19pm
6-K
CMMB
Chemomab Therapeutics Ltd
7 Mar 24
Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results
7:00am
6-K
CMMB
Chemomab Therapeutics Ltd
3 Jan 24
Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary
7:00am
SC 13D/A
OrbiMed Israel BioFund GP Limited Partnership
15 Nov 23
Chemomab Therapeutics / OrbiMed Israel BioFund GP Limited Partnership ownership change
4:35pm
6-K
CMMB
Chemomab Therapeutics Ltd
9 Nov 23
Current report (foreign)
8:00am
EFFECT
CMMB
Chemomab Therapeutics Ltd
6 Nov 23
Notice of effectiveness
12:15am
CORRESP
CMMB
Chemomab Therapeutics Ltd
1 Nov 23
Correspondence with SEC
12:00am
F-3/A
CMMB
Chemomab Therapeutics Ltd
30 Oct 23
Shelf registration (foreign) (amended)
8:33am
F-3
CMMB
Chemomab Therapeutics Ltd
16 Oct 23
Shelf registration (foreign)
4:25pm
6-K
CMMB
Chemomab Therapeutics Ltd
14 Aug 23
Current report (foreign)
8:05am
6-K
CMMB
Chemomab Therapeutics Ltd
8 Aug 23
Current report (foreign)
6:00am
4
Nissim Darvish
5 Jul 23
Chemomab Therapeutics / Nissim Darvish ownership change
5:48pm
6-K
CMMB
Chemomab Therapeutics Ltd
3 Jul 23
Current report (foreign)
3:49pm
4
CMMB
Chemomab Therapeutics Ltd
20 Jun 23
Chemomab Therapeutics / Jill M. Quigley ownership change
6:03am
4
CMMB
Chemomab Therapeutics Ltd
16 Jun 23
Chemomab Therapeutics / Sigal Fatal ownership change
4:03pm